Literature DB >> 18823715

Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy.

Ik Jae Lee1, Jinsil Seong, Su Jung Shim, Kwang Hyub Han.   

Abstract

PURPOSE: The purpose of this study was to identify radiotherapeutic parameters for predicting the occurrence of liver complications induced by radiotherapy of a liver tumor. METHODS AND MATERIALS: From 2001 to 2003, a total of 131 patients with hepatocellular carcinoma received three-dimensional conformal radiotherapy. The total dose was determined by the fraction of nontumor liver receiving 50% of the isocenter dose (V(50%)). We evaluated three sets of published radiation dose guidelines using nontumor liver volume or a combination of nontumor liver volume and hepatic functional reserve. The V(50%) was divided into three intervals (<33%, 33-66%, and >66%) and four categories (<25%, 25-49%, 50-75%, and >75%) according to guidelines by the University of Michigan and the Yonsei University, respectively. According to the guideline of Cheng et al., the radiation dose was determined by the indocyanin green retention rate at 15 min (ICG-R15) and the nontumor liver volume.
RESULTS: Of the 131 patients, 13 patients (9.9%) presented with liver complications. The incidence was 11.1%, 10.3%, and 18.2%, respectively, for a V(50%) of less than 33%, 33% to 66%, and more than 66%. The observed hepatic toxicity incidence was 10%, 12.1%, and 10.4% respectively for a V(50%) of less than 25%, 25% to 49%, and 50% to 75%, respectively. Nontumor liver volume and ICG-R15 were not predictors of liver complications. The incidence of liver complications was significantly increased in patients with Child-Pugh Class B (p = 0.044).
CONCLUSIONS: The parameter, V(50%), can be divided into 4 categories and used to predict acceptable toxicity. Furthermore, indicators of liver functional status like the Child-Pugh class may be more important and useful parameters than ICG-R15 for predicting radiation-related liver disease.

Entities:  

Mesh:

Year:  2008        PMID: 18823715     DOI: 10.1016/j.ijrobp.2008.04.035

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

1.  Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models.

Authors:  Matthew H Stenmark; Yue Cao; Hesheng Wang; Andrew Jackson; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence; Mary Feng
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

2.  Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma.

Authors:  Hong In Yoon; Ik Jae Lee; Kwang-Hyub Han; Jinsil Seong
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-09       Impact factor: 4.553

3.  Helical tomotherapy for single and multiple liver tumours.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Fu-Min Fang; Te-Jen Su; Stephen W Leung; Hsuan-Chih Hsu
Journal:  Radiat Oncol       Date:  2010-06-24       Impact factor: 3.481

Review 4.  Challenge and hope in radiotherapy of hepatocellular carcinoma.

Authors:  Jinsil Seong
Journal:  Yonsei Med J       Date:  2009-10-20       Impact factor: 2.759

Review 5.  Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma.

Authors:  Hong In Yoon; Jinsil Seong
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

6.  Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma.

Authors:  Issam El Naqa; Adam Johansson; Dawn Owen; Kyle Cuneo; Yue Cao; Martha Matuszak; Latifa Bazzi; Theodore S Lawrence; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-01       Impact factor: 7.038

7.  Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma.

Authors:  Seok Hyun Son; Chul Seung Kay; Jin Ho Song; Sea-Won Lee; Byung Ock Choi; Young Nam Kang; Jeong Won Jang; Seung Kew Yoon; Hong Seok Jang
Journal:  Radiat Oncol       Date:  2013-01-09       Impact factor: 3.481

8.  Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study.

Authors:  Ik Jae Lee; Jinsil Seong; Jung Im Bae; Sei Hwan You; Yumie Rhee; Jong Ho Lee
Journal:  Cancer Res Treat       Date:  2011-03-31       Impact factor: 4.679

9.  Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma.

Authors:  Seok Hyun Son; Hong Seok Jang; Hyochun Lee; Byung Ock Choi; Young Nam Kang; Jeong Won Jang; Seung Kew Yoon; Chul Seung Kay
Journal:  Radiat Oncol       Date:  2013-03-15       Impact factor: 3.481

10.  Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma.

Authors:  Seok Hyun Son; Hong Seok Jang; In-Young Jo; Byung Ock Choi; Jeong Won Jang; Seung Kew Yoon; Chul Seung Kay
Journal:  Radiat Oncol       Date:  2014-04-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.